Poor countries forecast relief as WHO adds seven Generic drugs to its list

22 August, 2005

Ranbaxy’s seven anti AIDS drugs have found place in the WHO’s prequalification list for use in poor countries. Three anti AIDS drugs by Aurobindo Pharma has also been successfully added to the list.

Last year three Ranbaxy generic drugs were dropped due to its lack of quality and safety in manufacturing drugs. According to latest WHO tests, the Ranbaxy products and laboratories have been found to be satisfactory. The whole purpose of prequalification list is to make it simpler for countries to determine which drugs to buy when they are planning anti AIDS program. For countries badly hit by AIDS epidemic, access to life prolonging drugs is a major benefit. This approval brings the WHO prequalification list to 63 out of which nearly half are generic drugs.

For more information read:
http://www.news-medical.net/?id=12575